MILLER; Craig Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for MILLER; Craig Andrew.The latest application filed is for "heteroaryl carboxamide compounds as inhibitors of ripk2".

Company Profile

1.14.11

MILLER; Craig Andrew - New Milford CT
Miller; Craig Andrew - Norwalk CT US
Miller; Craig Andrew - Mount Vernon NY
Miller; Craig Andrew - Mt. Vernon NY
Miller; Craig Andrew - Ridgefield CT
Miller; Craig Andrew - Danbury CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heteroaryl Carboxamide Compounds As Inhibitors Of Ripk2 App 20220081437 - LIU; Pingrong ; et al.	2022-03-17
Substituted benzamides as RIPK2 inhibitors Grant 11,130,754 - Liu , et al. September 28, 2	2021-09-28
Heteroaryl Carboxamide Compounds As Inhibitors Of Ripk2 App 20190048000 - LIU; Pingrong ; et al.	2019-02-14
Substituted benzamides as RIPK2 inhibitors Grant 10,138,222 - Cui , et al. Nov	2018-11-27
Substituted benzamides as RIPK2 inhibitors Grant 10,138,241 - Liu , et al. Nov	2018-11-27
Pyridine And Pyrazine Compounds As Inhibitors Of Ripk2 App 20180072703 - CUI; Jianwen ; et al.	2018-03-15
Heteroaryl Carboxamide Compounds As Inhibitors Of Ripk2 App 20180072717 - LIU; Pingrong ; et al.	2018-03-15
Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them Grant 8,859,814 - Cogan , et al. October 14, 2	2014-10-14
2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 Grant 8,586,748 - Abeywardane , et al. November 19, 2	2013-11-19
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides Grant 8,575,360 - Lemieux , et al. November 5, 2	2013-11-05
Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides Grant 8,552,205 - Barbosa, Jr. , et al. October 8, 2	2013-10-08
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES App 20120252817 - Lemieux; Rene Marc ; et al.	2012-10-04
Alpha-substituted N-sulfonyl Gylcine Amides Antagonists Of Ccr10, Compositions Containing The Same And Methods For Using Them App 20110275612 - Cogan; Derek ; et al.	2011-11-10
2-sulfonylamino-4-heteroaryl Butyramide Antagonists Of Ccr10 App 20110275800 - Abeywardane; Asitha ; et al.	2011-11-10
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES App 20110224188 - Barbosa; Antonio Jose del Moral ; et al.	2011-09-15
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors Grant 7,790,712 - Cogan , et al. September 7, 2	2010-09-07
Anti-Cytokine Heterocyclic Compounds App 20100190773 - ABEYWARDANE; Asitha ; et al.	2010-07-29
Anti-cytokine heterocyclic compounds Grant 7,514,458 - Cogan , et al. April 7, 2	2009-04-07
Anti-Cytokine Heterocyclic Compounds App 20070142371 - Cogan; Derek ; et al.	2007-06-21
Anti-cytokine heterocyclic compounds Grant 7,214,802 - Cogan , et al. May 8, 2	2007-05-08
Anti-cytokine heterocyclic compounds App 20060079519 - Cogan; Derek ; et al.	2006-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.